Friedreich ataxia?update on pathogenesis and possible therapies
- 1 February 2004
- journal article
- review article
- Published by Springer Nature in neurogenetics
- Vol. 5 (1) , 1-8
- https://doi.org/10.1007/s10048-003-0170-z
Abstract
Friedreich ataxia is the most-common inherited ataxia. Since the causative genetic basis was described in 1996, much has been learnt about the pathogenesis from human, animal, and yeast studies. This has led to the development of rational therapeutic approaches. In this review, the current state of knowledge regarding the pathogenesis of Friedreich ataxia is presented and possible therapeutic strategies based on this knowledge are discussed.Keywords
This publication has 95 references indexed in Scilit:
- Antioxidants as treatment for neurodegenerative disordersExpert Opinion on Investigational Drugs, 2002
- Frataxin knockin mousePublished by Wiley ,2002
- Respiratory deficiency due to loss of mitochondrial DNA in yeast lacking the frataxin homologueNature Genetics, 1997
- Studies of human, mouse and yeast homologues indicate a mitochondrial function for frataxinNature Genetics, 1997
- Protective effects of idebenone against alterations in dynamic microstructure induced by lipid peroxidation in rat cardiac mitochondria.Japanese Heart Journal, 1991
- Inhibition of lipid peroxidation by idebenone in brain mitochondria in the presence of succinateArchives of Gerontology and Geriatrics, 1989
- Stimulation of the respiratory and phosphorylating activities in rat brain mitochondria by idebenone (CV‐2619), a new agent improving cerebral metabolismFEBS Letters, 1985
- Inhibition of lipid peroxidation by a novel compound (CV-2619) in brain mitochondria and mode of action of the inhibitionBiochemical and Biophysical Research Communications, 1984
- Mobilization of iron from reticulocytesFEBS Letters, 1979
- Effect of Desferrioxamine and D.T.P.A. in Iron OverloadBMJ, 1962